Cargando…
Systematic review, network meta-analysis and economic evaluation of biological therapy for the management of active psoriatic arthritis
BACKGROUND: An updated economic evaluation was conducted to compare the cost-effectiveness of the four tumour necrosis factor (TNF)-α inhibitors adalimumab, etanercept, golimumab and infliximab in active, progressive psoriatic arthritis (PsA) where response to standard treatment has been inadequate....
Autores principales: | Cawson, Matthew Richard, Mitchell, Stephen Andrew, Knight, Chris, Wildey, Henry, Spurden, Dean, Bird, Alex, Orme, Michelle Elaine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903562/ https://www.ncbi.nlm.nih.gov/pubmed/24444034 http://dx.doi.org/10.1186/1471-2474-15-26 |
Ejemplares similares
-
Systematic review and network meta-analysis of combination and monotherapy treatments in disease-modifying antirheumatic drug-experienced patients with rheumatoid arthritis: analysis of American College of Rheumatology criteria scores 20, 50, and 70
por: Orme, Michelle E, et al.
Publicado: (2012) -
Economic impact of biologic utilization patterns in patients with psoriatic arthritis
por: Schwartzman, Sergio, et al.
Publicado: (2017) -
Altered Bone Biology in Psoriatic Arthritis
por: Rahimi, Homaira, et al.
Publicado: (2012) -
An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis
por: Chimenti, Maria Sole, et al.
Publicado: (2020) -
Immunogenicity to biological drugs in psoriasis and psoriatic arthritis
por: Valenzuela, Fernando, et al.
Publicado: (2021)